APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Receptor Tyrosine Protein Kinase TYK2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non Receptor Tyrosine Protein Kinase TYK2 Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchNon Receptor Tyrosine Protein Kinase TYK2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Receptor Tyrosine Protein Kinase TYK2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non Receptor Tyrosine Protein Kinase TYK2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non Receptor Tyrosine Protein Kinase TYK2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non Receptor Tyrosine Protein Kinase TYK2 market include Takeda Pharmaceutical Company Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Theravance Biopharma Inc, Sareum Holdings Plc, Portola Pharmaceuticals Inc, Nimbus Therapeutics LLC and Array BioPharma Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non Receptor Tyrosine Protein Kinase TYK2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non Receptor Tyrosine Protein Kinase TYK2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non Receptor Tyrosine Protein Kinase TYK2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non Receptor Tyrosine Protein Kinase TYK2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Company

Takeda Pharmaceutical Company Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nimbus Therapeutics LLC

Array BioPharma Inc

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Type

ARRY-624

BMS-986165

NDI-031232

Cerdulatinib

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Application

Follicular Lymphoma

Lupus Nephritis

Hypersensitivity

Marginal Zone B-cell Lymphoma

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non Receptor Tyrosine Protein Kinase TYK2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non Receptor Tyrosine Protein Kinase TYK2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non Receptor Tyrosine Protein Kinase TYK2 significant trends, drivers, influence factors in global and regions.

6. To analyze Non Receptor Tyrosine Protein Kinase TYK2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Receptor Tyrosine Protein Kinase TYK2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Receptor Tyrosine Protein Kinase TYK2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Receptor Tyrosine Protein Kinase TYK2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non Receptor Tyrosine Protein Kinase TYK2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non Receptor Tyrosine Protein Kinase TYK2 industry.

Chapter 3: Detailed analysis of Non Receptor Tyrosine Protein Kinase TYK2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non Receptor Tyrosine Protein Kinase TYK2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non Receptor Tyrosine Protein Kinase TYK2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends Table 2. Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers Table 3. Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges Table 4. Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints Table 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Company (2021-2026) Table 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Company (2021-2026) Table 9. Global Non Receptor Tyrosine Protein Kinase TYK2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non Receptor Tyrosine Protein Kinase TYK2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non Receptor Tyrosine Protein Kinase TYK2 Key Company Manufacturing Base & Headquarters Table 12. Global Non Receptor Tyrosine Protein Kinase TYK2 Company, Product Type & Application Table 13. Global Non Receptor Tyrosine Protein Kinase TYK2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non Receptor Tyrosine Protein Kinase TYK2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ARRY-624 Table 18. Significant Companies of BMS-986165 Table 19. Significant Companies of NDI-031232 Table 20. Significant Companies of Cerdulatinib Table 21. Significant Companies of Others Table 22. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Type (2021-2026) Table 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Type (2027-2032) Table 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type (2021-2026) Table 31. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Follicular Lymphoma Table 33. Significant Companies of Lupus Nephritis Table 34. Significant Companies of Hypersensitivity Table 35. Significant Companies of Marginal Zone B-cell Lymphoma Table 36. Significant Companies of Others Table 37. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Application (2021-2026) Table 41. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Application (2027-2032) Table 42. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application (2021-2026) Table 46. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application (2027-2032) Table 47. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026) & (K Units) Table 49. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2026) Table 50. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2027-2032) & (K Units) Table 51. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2027-2032) Table 52. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Region (2021-2026) Table 55. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Region (2027-2032) Table 57. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 62. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2026) Table 63. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 64. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2027-2032) Table 65. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Market Share by Country (2021-2026) Table 67. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Market Share by Country (2027-2032) Table 69. Takeda Pharmaceutical Company Ltd Company Information Table 70. Takeda Pharmaceutical Company Ltd Business Overview Table 71. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 73. Takeda Pharmaceutical Company Ltd Recent Development Table 74. Pfizer Inc Company Information Table 75. Pfizer Inc Business Overview Table 76. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 78. Pfizer Inc Recent Development Table 79. Bristol-Myers Squibb Company Company Information Table 80. Bristol-Myers Squibb Company Business Overview Table 81. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 83. Bristol-Myers Squibb Company Recent Development Table 84. Theravance Biopharma Inc Company Information Table 85. Theravance Biopharma Inc Business Overview Table 86. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 88. Theravance Biopharma Inc Recent Development Table 89. Sareum Holdings Plc Company Information Table 90. Sareum Holdings Plc Business Overview Table 91. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 93. Sareum Holdings Plc Recent Development Table 94. Portola Pharmaceuticals Inc Company Information Table 95. Portola Pharmaceuticals Inc Business Overview Table 96. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 98. Portola Pharmaceuticals Inc Recent Development Table 99. Nimbus Therapeutics LLC Company Information Table 100. Nimbus Therapeutics LLC Business Overview Table 101. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 103. Nimbus Therapeutics LLC Recent Development Table 104. Array BioPharma Inc Company Information Table 105. Array BioPharma Inc Business Overview Table 106. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 108. Array BioPharma Inc Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Non Receptor Tyrosine Protein Kinase TYK2 Distributors List Table 112. Non Receptor Tyrosine Protein Kinase TYK2 Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Non Receptor Tyrosine Protein Kinase TYK2 Product Image Figure 2. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (2021-2032) & (K Units) Figure 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ARRY-624 Image Figure 10. BMS-986165 Image Figure 11. NDI-031232 Image Figure 12. Cerdulatinib Image Figure 13. Others Image Figure 14. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Type (2021-2032) Figure 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type (2021-2032) Figure 20. Follicular Lymphoma Image Figure 21. Lupus Nephritis Image Figure 22. Hypersensitivity Image Figure 23. Marginal Zone B-cell Lymphoma Image Figure 24. Others Image Figure 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Application (2021-2032) Figure 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application (2021-2032) Figure 31. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 36. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 42. South America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Non Receptor Tyrosine Protein Kinase TYK2 Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • ARRY-624
  • BMS-986165
  • NDI-031232
  • Cerdulatinib
  • Others
Applications
  • Follicular Lymphoma
  • Lupus Nephritis
  • Hypersensitivity
  • Marginal Zone B-cell Lymphoma
  • Others
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nimbus Therapeutics LLC
  • Array BioPharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  4. 1.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume (2021-2032)
  5. 1.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non Receptor Tyrosine Protein Kinase TYK2 Market Dynamics
  1. 2.1 Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends
  2. 2.2 Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers
  3. 2.3 Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges
  4. 2.4 Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints
3 Non Receptor Tyrosine Protein Kinase TYK2 Market by Company
  1. 3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Company Revenue Ranking in 2025
  2. 3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Company (2021-2026)
  3. 3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Average Price by Company (2021-2026)
  5. 3.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Company Ranking (2024-2026)
  6. 3.6 Global Non Receptor Tyrosine Protein Kinase TYK2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Non Receptor Tyrosine Protein Kinase TYK2 Company Product Type and Application
  8. 3.8 Global Non Receptor Tyrosine Protein Kinase TYK2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non Receptor Tyrosine Protein Kinase TYK2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non Receptor Tyrosine Protein Kinase TYK2 Market by Type
  1. 4.1 Non Receptor Tyrosine Protein Kinase TYK2 Type Introduction
  2. 4.1.1 ARRY-624
  3. 4.1.2 BMS-986165
  4. 4.1.3 NDI-031232
  5. 4.1.4 Cerdulatinib
  6. 4.1.5 Others
  7. 4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type
  8. 4.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type
  12. 4.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type (2021-2032)
5 Non Receptor Tyrosine Protein Kinase TYK2 Market by Application
  1. 5.1 Non Receptor Tyrosine Protein Kinase TYK2 Application Introduction
  2. 5.1.1 Follicular Lymphoma
  3. 5.1.2 Lupus Nephritis
  4. 5.1.3 Hypersensitivity
  5. 5.1.4 Marginal Zone B-cell Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application
  8. 5.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application
  12. 5.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Application (2021-2032)
  14. 5.3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application (2021-2032)
6 Non Receptor Tyrosine Protein Kinase TYK2 Regional Sales and Value Analysis
  1. 6.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2032)
  3. 6.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021-2026
  4. 6.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2027-2032)
  5. 6.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Region (2027-2032)
  9. 6.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  12. 6.6.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  15. 6.7.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  21. 6.9.2 South America Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Country, 2025 VS 2032
7 Non Receptor Tyrosine Protein Kinase TYK2 Country-level Sales and Value Analysis
  1. 7.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  4. 7.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026)
  5. 7.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032)
  6. 7.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Ltd
  2. 8.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 8.2 Pfizer Inc
  8. 8.2.1 Pfizer Inc Company Information
  9. 8.2.2 Pfizer Inc Business Overview
  10. 8.2.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  12. 8.2.5 Pfizer Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Company
  14. 8.3.1 Bristol-Myers Squibb Company Company Information
  15. 8.3.2 Bristol-Myers Squibb Company Business Overview
  16. 8.3.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 8.4 Theravance Biopharma Inc
  20. 8.4.1 Theravance Biopharma Inc Company Information
  21. 8.4.2 Theravance Biopharma Inc Business Overview
  22. 8.4.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  24. 8.4.5 Theravance Biopharma Inc Recent Developments
  25. 8.5 Sareum Holdings Plc
  26. 8.5.1 Sareum Holdings Plc Company Information
  27. 8.5.2 Sareum Holdings Plc Business Overview
  28. 8.5.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  30. 8.5.5 Sareum Holdings Plc Recent Developments
  31. 8.6 Portola Pharmaceuticals Inc
  32. 8.6.1 Portola Pharmaceuticals Inc Company Information
  33. 8.6.2 Portola Pharmaceuticals Inc Business Overview
  34. 8.6.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  36. 8.6.5 Portola Pharmaceuticals Inc Recent Developments
  37. 8.7 Nimbus Therapeutics LLC
  38. 8.7.1 Nimbus Therapeutics LLC Company Information
  39. 8.7.2 Nimbus Therapeutics LLC Business Overview
  40. 8.7.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  42. 8.7.5 Nimbus Therapeutics LLC Recent Developments
  43. 8.8 Array BioPharma Inc
  44. 8.8.1 Array BioPharma Inc Company Information
  45. 8.8.2 Array BioPharma Inc Business Overview
  46. 8.8.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  48. 8.8.5 Array BioPharma Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Analysis
  2. 9.1.1 Non Receptor Tyrosine Protein Kinase TYK2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non Receptor Tyrosine Protein Kinase TYK2 Sales Mode & Process
  6. 9.2 Non Receptor Tyrosine Protein Kinase TYK2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
  9. 9.2.3 Non Receptor Tyrosine Protein Kinase TYK2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst